Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.30 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.30 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18701466 | 0.89 | SMN1; SMN2 (0.33) | LMNASMN1; SMN2CYP17A1CYP3A4CYP19A1 | |
| SCHEMBL20041626 | 0.88 | SMN1; SMN2 (0.37) | LMNASMN1; SMN2CYP17A1CYP3A4CYP19A1 | |
| SCHEMBL18701308 | 0.84 | DHFR (0.32) | LMNASMN1; SMN2 | |
| SCHEMBL26528200 | 0.76 | NQO2 (0.39) | LMNASMN1; SMN2RAB9ATSHR | |
| SCHEMBL18701467 | 0.76 | DHFR (0.32) | LMNASMN1; SMN2 | |
| SCHEMBL24452013 | 0.75 | THRB (0.36) | LMNA | |
| SCHEMBL20041768 | 0.75 | KDM4E (0.40) | LMNASMN1; SMN2TSHR | |
| SCHEMBL24452006 | 0.74 | THRB (0.35) | LMNA | |
| SCHEMBL24452064 | 0.73 | MPO (0.31) | — | |
| SCHEMBL20041733 | 0.73 | ALOX5 (0.46) | LMNASMN1; SMN2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170098783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2017-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170098783-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | EED, EML4, MT-ND4L | LMNA 2908/4885SMN1; SMN2 4302/4885CYP17A1 4629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.